| Group | Condition | HP15_435 |
|---|
| pro99_seawater | monoculture; Experiment A, time point 7 | -5.2 |
| pro99_seawater | monoculture; Experiment C, time point 6 | -4.4 |
| pro99_seawater | monoculture; Experiment B, time point 7 | -4.3 |
| pro99_seawater | monoculture; Experiment C, time point 4 | -3.3 |
| pro99_seawater | monoculture; Experiment B, time point 5 | -3.1 |
| pro99_seawater | monoculture; Experiment C, time point 5 | -2.9 |
| pro99_seawater | monoculture; Experiment A, time point 5 | -2.8 |
| pro99_seawater | monoculture; Experiment B, time point 4 | -2.6 |
| pro99_seawater | monoculture; Experiment A, time point 4 | -2.5 |
| pro99_seawater | monoculture; Experiment C, time point 3 | -2.2 |
| mixed community | Mixed culture; Synechococcus str. WH8102 10:1 starting OD to HP15 | -2.1 |
| stress | m.b. Thallium(I) acetate 0.016 mg/ml | -2.0 |
| pro99_seawater | monoculture; Experiment C, time point 2 | -2.0 |
| mixed community | Mixed culture; Synechococcus str. WH8102 10:1 starting OD to HP15 | -2.0 |
| pro99_seawater | monoculture; Experiment A, time point 3 | -2.0 |
| stress | m.b. Thallium(I) acetate 0.016 mg/ml | -1.9 |
| stress | m.b. Cisplatin 0.025 mg/ml | -1.8 |
| mixed community | Mixed culture; Prochlorococcus marinus str. MED4 10:1 starting OD to HP15 | -1.8 |
| stress | m.b. Cisplatin 0.025 mg/ml | -1.8 |
| stress | m.b. Cisplatin 0.025 mg/ml | -1.8 |
| stress | m.b. Thallium(I) acetate 0.016 mg/ml | -1.8 |
| pro99_seawater | monoculture; Experiment B, time point 2 | -1.7 |
| pro99_seawater | monoculture; Experiment A, time point 2 | -1.6 |
| pro99_seawater | Control growth in Pro99_seawater | -1.6 |
| carbon source | Glycerol | -1.6 |
| vitamin | No vitamins, second passage | -1.5 |
| mixed community | Mixed culture; Prochlorococcus marinus str. MED4 10:1 starting OD to HP15 | -1.5 |
| nitrogen source | L-Citrulline as (N) | +1.4 |
| stress | m.b. Cholin acetate 153.15 mM | +1.6 |
| stress | m.b. Sisomicin 0.008 mg/ml | +1.9 |
| | remove
HP15_435 |